One limitation of the study is that the examined tissues are post-chemotherapy resected tumors and that activation of mTOR pathway could be due to chemotherapy treatment rather than by the tumor-specific genetic or epigenetic alterations. The gene discussed is MTOR; the disease is neoplasm.